Universitaetsklinikum Augsburg — Augsburg

Public research footprint of Universitaetsklinikum Augsburg, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute… · Locally Advanced Basal Cell Carcinoma · Triple-negative Breast Cancer · Ulcerative Colitis, Unspecified

Recently updated registry entries

NCT07227350 — L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) (Recruiting)
NCT07197307 — Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large… (Recruiting)
NCT06527404 — A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo… (Terminated)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Universitaetsklinikum Augsburg?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.